-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIOTHERAPEUTICS INC - TO ADVANCE SAB-142 INTO PHASE 2B TRIAL IN 2025

Reuters·01/28/2025 12:01:38

Please log in to view news